help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohseni-Zadeh, S.
Right arrow Articles by Binoux, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohseni-Zadeh, S.
Right arrow Articles by Binoux, M.
Endocrinology Vol. 138, No. 12 5645-5648
Copyright © 1997 by The Endocrine Society

ARTICLES

Insulin-Like Growth Factor (IGF) Binding Protein-3 Interacts with the Type 1 IGF Receptor, Reducing the Affinity of the Receptor for its Ligand: An Alternative Mechanism in the Regulation of IGF Action

Sarah Mohseni-Zadeh and Michel Binoux

Institut National de la Santé et de la Recherche Médicale, U.142, Hôpital Saint Antoine, 75571 Paris Cedex 12, France

Address all correspondence and requests for reprints to: Michel Binoux, M.D., INSERM U142, Hôpital Saint-Antoine, 184 rue du Faubourg Saint Antoine, 75571 Paris Cedex 12, France.

With a view to determining the mechanisms by which insulin-like growth factor binding protein-3 (IGFBP-3) and its proteolytic fragments modulate IGF action, we used a fibroblast cell line to investigate the possibility of an interaction with the type 1 IGF receptor (IGFR-1). In competitive binding experiments, IGFBP-3 was as potent as unlabelled IGF-I in displacing its truncated analogue, 125I-des(1-3)IGF-I, which has weak affinity for IGFBPs, from its binding to the cell surface. None of the proteolytic fragments of IGFBP-3 tested affected this binding. IGFBP-3 had no effect on insulin binding to its receptor. At 10 nM, IGFBP-1 was ineffective where IGFBP-3 provoked 90% displacement of 125I-des(1-3)IGF-I, but it was equally potent in displacing 125I-IGF-I. At the same concentration, binding of 125I-des(1-3)IGF-I to free IGFBP-3 in the supernatant was only 2%. After pre-incubation of the cells with 125I-des(1-3)IGF-I, low concentrations of IGFBP-3 were as potent at IGF-I in dissociating IGFR-1-bound ligand. After preincubation of cells with IGFBP-3, washing and then incubation with 125I-des(1-3)IGF-I, inhibition by low IGFBP-3 concentrations was suppressed, but some degree of inhibition by high concentrations persisted. At these high concentrations, addition of IGF-I restored binding owing to uptake of cell-associated IGFBP-3. The present results provide the first evidence that IGFBP-3 may inhibit IGF binding to IGFR-1, and hence limit IGF action via a cellular mechanism that is different from the extracellular mechanism of sequestration.




This article has been cited by other articles:


Home page
 Reproductive SciencesHome page
S. C.J.P. Gielen, E. E. Hanekamp, L. J. Blok, F. J. Huikeshoven, and C. W. Burger
Steroid-Modulated Proliferation of Human Endometrial Carcinoma Cell Lines: Any Role for Insulin-like Growth Factor Signaling?
Reproductive Sciences, January 1, 2005; 12(1): 58 - 64.
[Abstract] [PDF]

Home page
 IOVSHome page
J. L. King and C. Guidry
Insulin-Like Growth Factor Binding Proteins Modulate Muller Cell Responses to Insulin-Like Growth Factors
Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2848 - 2855.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
C. Lassarre and J.-M. Ricort
Growth Factor-Specific Regulation of Insulin Receptor Substrate-1 Expression in MCF-7 Breast Carcinoma Cells: Effects on the Insulin-Like Growth Factor Signaling Pathway
Endocrinology, November 1, 2003; 144(11): 4811 - 4819.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. M. Firth and R. C. Baxter
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Endocr. Rev., December 1, 2002; 23(6): 824 - 854.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
T. A. Davis, M. L. Fiorotto, D. G. Burrin, R. C. Vann, P. J. Reeds, H. V. Nguyen, P. R. Beckett, and J. A. Bush
Acute IGF-I infusion stimulates protein synthesis in skeletal muscle and other tissues of neonatal pigs
Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E638 - E647.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J.-M. Ricort and M. Binoux
Insulin-like Growth Factor-binding Protein-3 Activates a Phosphotyrosine Phosphatase. EFFECTS ON THE INSULIN-LIKE GROWTH FACTOR SIGNALING PATHWAY
J. Biol. Chem., May 24, 2002; 277(22): 19448 - 19454.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
D. R. Clemmons
Use of Mutagenesis to Probe IGF-Binding Protein Structure/Function Relationships
Endocr. Rev., December 1, 2001; 22(6): 800 - 817.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J.-M. Ricort and M. Binoux
Insulin-Like Growth Factor (IGF) Binding Protein-3 Inhibits Type 1 IGF Receptor Activation Independently of Its IGF Binding Affinity
Endocrinology, January 1, 2001; 142(1): 108 - 113.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Salahifar, R. C. Baxter, and J. L. Martin
Differential Regulation of Insulin-Like Growth Factor-Binding Protein-3 Protease Activity in MCF-7 Breast Cancer Cells by Estrogen and Transforming Growth Factor-{beta}1
Endocrinology, September 1, 2000; 141(9): 3104 - 3110.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
R. C. Baxter
Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities
Am J Physiol Endocrinol Metab, June 1, 2000; 278(6): E967 - E976.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
K. R. Kritsch, D. J. Huss, and D. M. Ney
Greater potency of IGF-I than IGF-I/BP-3 complex in catabolic parenterally fed rats
Am J Physiol Endocrinol Metab, February 1, 2000; 278(2): E252 - E262.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. J. Smink, J. G. Koster, B. I. Hendriks-Stegeman, and S. C. van Buul-Offers
Insulin-Like Growth Factor (IGF) II Induced Changes in Expression of IGF Binding Proteins in Lymphoid Tissues of hIGF-II Transgenic Mice
Endocrinology, December 1, 1999; 140(12): 5876 - 5882.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice
The Insulin-Related Ovarian Regulatory System in Health and Disease
Endocr. Rev., August 1, 1999; 20(4): 535 - 582.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
V. C. Russo, G. Rekaris, N. L. Baker, L. A. Bach, and G. A. Werther
Basic Fibroblast Growth Factor Induces Proteolysis of Secreted and Cell Membrane-Associated Insulin-Like Growth Factor Binding Protein-2 in Human Neuroblastoma Cells
Endocrinology, July 1, 1999; 140(7): 3082 - 3090.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
W. A. Price
Peptide Growth Factors Regulate Insulin-Like Growth Factor Binding Protein Production by Fetal Rat Lung Fibroblasts
Am. J. Respir. Cell Mol. Biol., February 1, 1999; 20(2): 332 - 341.
[Abstract] [Full Text]

Home page
 EndocrinologyHome page
E. Svanberg, L. Powell-Braxton, C. Ohlsson, H. Zachrisson, and K. Lundholm
The Role of the Growth Hormone/Insulin-Like Growth Factor I Axis in Stimulation of Protein Synthesis in Skeletal Muscles Following Oral Refeeding
Endocrinology, December 1, 1998; 139(12): 4906 - 4910.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society